Cargando…

A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome

INTRODUCTION: Multisystem inflammatory syndrome (MIS-C) is associated with the novel coronavirus (COVID-19). Children and young adults with MIS-C typically present with fever, abdominal pain, nausea, vomiting, and occasionally, respiratory symptoms. Myocardial dysfunction (as measured by TTE, elevat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mithoefer, O.J., LeCluyse, J., Jackson, G.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988594/
http://dx.doi.org/10.1016/j.healun.2022.01.696
_version_ 1784682996470644736
author Mithoefer, O.J.
LeCluyse, J.
Jackson, G.R.
author_facet Mithoefer, O.J.
LeCluyse, J.
Jackson, G.R.
author_sort Mithoefer, O.J.
collection PubMed
description INTRODUCTION: Multisystem inflammatory syndrome (MIS-C) is associated with the novel coronavirus (COVID-19). Children and young adults with MIS-C typically present with fever, abdominal pain, nausea, vomiting, and occasionally, respiratory symptoms. Myocardial dysfunction (as measured by TTE, elevated troponin, or elevated brain natriuretic peptide [BNP]) has been reported in 51-90% of these patients. CASE REPORT: An 18-year-old male without significant medical history was transferred to the Cardiovascular Intensive Care Unit with cardiogenic shock after presenting with headache, myalgias, sore throat, nausea, and vomiting. Initial workup revealed hypotension, tachycardia, and positive SARS-CoV-2 IgG antibodies. Transthoracic echocardiogram (TTE) showed severe biventricular failure with left ventricular ejection fraction (LVEF) of 26%. Vasopressors were started for blood pressure support. Right heart catheterization (RHC) was consistent with cardiogenic shock. Impella CP percutaneous left ventricular assist device was placed. The patient developed hypoxemia and tachypnea. He was intubated and underwent cannulation for veno-arterial extracorporeal membrane oxygenation (VA ECMO). He was also started on continuous renal replacement therapy (CRRT) for acute anuric renal failure. Endomyocardial biopsy revealed benign myocardium. Vasopressors were weaned and repeat TTE on day 3 revealed LVEF of 34%; subsequent TTE on day 5 showed recovery up to 53%. The Impella device was removed, VA ECMO was decannulated, and the patient was extubated. He improved clinically over the next weeks with normalizing vital signs, inflammatory markers, respiratory status, and renal function. The patient was discharged on day 28, about six weeks after symptom onset. TTE prior to discharge revealed mild LV hypertrophy and normal systolic function. SUMMARY: As illustrated in this case, timely recognition of cardiogenic shock is critical. This patient developed acute-onset cardiogenic shock, which required early escalation to temporary mechanical circulatory support. Additionally, this patient's care was complex and the case highlights the importance of early coordination between teams. Meetings were held nearly daily, with collaboration contributing to a multidisciplinary workup and treatment plan that ultimately led to the full recovery of this young patient.
format Online
Article
Text
id pubmed-8988594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89885942022-04-11 A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome Mithoefer, O.J. LeCluyse, J. Jackson, G.R. J Heart Lung Transplant (675) INTRODUCTION: Multisystem inflammatory syndrome (MIS-C) is associated with the novel coronavirus (COVID-19). Children and young adults with MIS-C typically present with fever, abdominal pain, nausea, vomiting, and occasionally, respiratory symptoms. Myocardial dysfunction (as measured by TTE, elevated troponin, or elevated brain natriuretic peptide [BNP]) has been reported in 51-90% of these patients. CASE REPORT: An 18-year-old male without significant medical history was transferred to the Cardiovascular Intensive Care Unit with cardiogenic shock after presenting with headache, myalgias, sore throat, nausea, and vomiting. Initial workup revealed hypotension, tachycardia, and positive SARS-CoV-2 IgG antibodies. Transthoracic echocardiogram (TTE) showed severe biventricular failure with left ventricular ejection fraction (LVEF) of 26%. Vasopressors were started for blood pressure support. Right heart catheterization (RHC) was consistent with cardiogenic shock. Impella CP percutaneous left ventricular assist device was placed. The patient developed hypoxemia and tachypnea. He was intubated and underwent cannulation for veno-arterial extracorporeal membrane oxygenation (VA ECMO). He was also started on continuous renal replacement therapy (CRRT) for acute anuric renal failure. Endomyocardial biopsy revealed benign myocardium. Vasopressors were weaned and repeat TTE on day 3 revealed LVEF of 34%; subsequent TTE on day 5 showed recovery up to 53%. The Impella device was removed, VA ECMO was decannulated, and the patient was extubated. He improved clinically over the next weeks with normalizing vital signs, inflammatory markers, respiratory status, and renal function. The patient was discharged on day 28, about six weeks after symptom onset. TTE prior to discharge revealed mild LV hypertrophy and normal systolic function. SUMMARY: As illustrated in this case, timely recognition of cardiogenic shock is critical. This patient developed acute-onset cardiogenic shock, which required early escalation to temporary mechanical circulatory support. Additionally, this patient's care was complex and the case highlights the importance of early coordination between teams. Meetings were held nearly daily, with collaboration contributing to a multidisciplinary workup and treatment plan that ultimately led to the full recovery of this young patient. Published by Elsevier Inc. 2022-04 2022-04-07 /pmc/articles/PMC8988594/ http://dx.doi.org/10.1016/j.healun.2022.01.696 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle (675)
Mithoefer, O.J.
LeCluyse, J.
Jackson, G.R.
A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome
title A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome
title_full A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome
title_fullStr A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome
title_full_unstemmed A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome
title_short A Case of Cardiogenic Shock in a Young Adult with COVID-19-Induced Multisystem Inflammatory Syndrome
title_sort case of cardiogenic shock in a young adult with covid-19-induced multisystem inflammatory syndrome
topic (675)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988594/
http://dx.doi.org/10.1016/j.healun.2022.01.696
work_keys_str_mv AT mithoeferoj acaseofcardiogenicshockinayoungadultwithcovid19inducedmultisysteminflammatorysyndrome
AT lecluysej acaseofcardiogenicshockinayoungadultwithcovid19inducedmultisysteminflammatorysyndrome
AT jacksongr acaseofcardiogenicshockinayoungadultwithcovid19inducedmultisysteminflammatorysyndrome
AT mithoeferoj caseofcardiogenicshockinayoungadultwithcovid19inducedmultisysteminflammatorysyndrome
AT lecluysej caseofcardiogenicshockinayoungadultwithcovid19inducedmultisysteminflammatorysyndrome
AT jacksongr caseofcardiogenicshockinayoungadultwithcovid19inducedmultisysteminflammatorysyndrome